Medivista Lifesciences Private Limited, a active private limited company, was established on 20 May 2015 in Panchkula, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100HR2015PTC055513. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jatinder Kumar Bansal (Director), Anita Bansal (Director), Nakul Bansal (Director). It holds no open charges and ₹0.80 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.399, Industrial Area Phase-Ii, Urban Estate, Panchkula, Haryana, 134109.
U24100HR2015PTC055513
055513
20 May 2015
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Medivista Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jatinder Kumar Bansal | Director | 20 May 2015 | Current |
| Anita Bansal | Director | 20 May 2015 | Current |
| Nakul Bansal | Director | 20 May 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medivista Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 70.47% increase. The company also saw a substantial fall in profitability, with a 36.67% decrease in profit. The company's net worth moved up by a moderate rise of 3.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medivista Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jul 2016 | Vijaya Bank | ₹0.80 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medivista Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medivista Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medivista Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medivista Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Medivista Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
A charge registered on 11 Jul 2016 via Charge ID 100047290 with Vijaya Bank was fully satisfied on 19 Feb 2021. was recorded as a recent event.
A charge with Vijaya Bank amounted to Rs. 0.80 M with Charge ID 100047290 was registered on 11 Jul 2016. was recorded as a recent event.
Jatinder Kumar Bansal was appointed as a Director was appointed as a Director on 20 May 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.
Progress on Anita Bansal was appointed as a Director was appointed as a Director on 20 May 2015 & has been associated with this company since 10 years 7 months . was documented.
The CIN of Medivista Lifesciences Private Limited is U24100HR2015PTC055513.
Medivista Lifesciences Private Limited is headquartered at Plot No.399, Industrial Area Phase-Ii, Urban Estate, Panchkula, Haryana, 134109.
Medivista Lifesciences Private Limited was incorporated on 20 May 2015.
The current directors of Medivista Lifesciences Private Limited are
The primary industry of Medivista Lifesciences Private Limited is Trade.
Medivista Lifesciences Private Limited is unlisted.
The authorized capital of Medivista Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Medivista Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX